Possible synergistic effect of metformin and enalapril on the development of hyperkaliemic lactic acidosis

Diabetes Research and Clinical Practice

Volumn 38, Issue 3, 1997, Pages 173-176

  Franzetti, Ivano ^a   Paolo, Donnini ^a   Marco, Gaiazzi ^a   Emanuela, Mazzola ^a   Elisabetta, Zibetti ^a   Renato, Uccella ^a  

^a OSPEDALE DI CIRCOLO   (Italy)

Author keywords

Enalapril; Hyperkaliemia; Metabolic acidosis; Metformin; Non insulin dependent diabetes mellitus

Indexed keywords

ANTIHYPERTENSIVE AGENT; BIGUANIDE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; METFORMIN; ORAL ANTIDIABETIC AGENT;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CASE REPORT; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG CONTRAINDICATION; DRUG POTENTIATION; FEMALE; HUMAN; HYPERKALEMIA; HYPERTENSION; IATROGENIC DISEASE; KIDNEY FAILURE; LACTIC ACIDOSIS; METABOLIC ACIDOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS;

ACIDOSIS; AGED; ANTIHYPERTENSIVE AGENTS; CHLORIDES; DIABETES MELLITUS, TYPE 2; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENALAPRIL; FEMALE; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; LACTIC ACID; METFORMIN;

EID: 0031418087     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(97)00098-3     Document Type: Article

References (15)

1. Brivet F., Bernardin M., Dormont J. Acidose hyperchlorémique au cours des acidoses métaboliques à trou anionique augmenté Presse Med. 20:1991;413-417.
2. Arieff A.I. Pathogenesis of lactic acidosis. Current concepts. Diabetes Rev. 2(2):1994;168-176.
3. Misbin R.I. Phenphormin-associated lactic acidosis: Pathogenesis and treatment. Ann. Intern. Med. 87:1977;591-595.
4. L.S. Hermann, Metabolic effects of metformin in relation to clinical effects and side-effects, in: A. Van Der Kuy, S.G.T. Hulst (Eds.), Biguanide Therapy Today, Royal Society of Medicine, International Congress and Symposium series 48, No.48, Academic Press, London, 1981, pp. 17-48.
5. Luft D., Schmulling R.M., Eggstein M. Lactic acidosis in biguanide treated diabetics: A review of 330 cases. Diabetologia. 14:1978;75-87.
6. Assan R., Heuclin C., Ganeval D., Bismuth C., George J., Girard J.R. Metformin-induced lactic acidosis in the presence of acute renal failure. Diabetologia. 13:1977;211-217.
7. Bailey C.J. Biguanides and NIDDM. Diabetes Care. 15:1992;755-772.
8. Waters A.K., Morgan B.B., Wales J.K. Blood lactate and pyruvate levels in diabetic patients treated with biguanides with and without sulphonylureas. Diabetologia. 14:1978;95-98.
9. Hammeke M., Bear R., Lee R., Goldstein M., Halperin M. Hyperchloremic metabolic acidosis in diabetes mellitus. Diabetes. 27:1978;16-20.
10. Madias N.E., Homer S.M., Johns C.A., Cohen J.J. Hypochloremia as a consequence of anion gap metabolic acidosis. J. Lab. Clin. Med. 104:1984;15-23.
11. Adrogue' H.J., Wison H., Boyd A.E., Suki W.N., Eknoyan G. Plasma acid-base pattern in diabetic ketoacidosis. New Engl. J. Med. 307:1982;1603-1610.
12. Halperin M., Goldstein M., Richardson M., Stinebaugh B. Distal renal tubular acidosis syndromes: A pathophysiological approach. Am. J. Nephrol. 5:1985;1-8.
13. Nelson E.B., Pool J.L., Taylor A.A. Pharmacology of angiotensin converting enzyme inhibitors. A review. Am. J. Med. 81(4c):1986;13-18.
14. Bailey C.J., Turner R.C. Metformin. New Engl. J. Med. 334:1996;574-579.
15. Josephkutty S., Potter J.M. Comparison of tolbutamide and metformin in elderly diabetic patients. Diabetic Med. 7:1990;510-514.